|
CHECK OUT OUR LATEST ISSUE
Recently, with the approval of a novel polymerase inhibitor, sofosbuvir (Sovaldi), and a second-generation protease inhibitor, simeprevir (Olysio), treatment of hepatitis C (HCV) has progressed dramatically. These new options offer better cure rates and are more tolerable; however, the costs associated with these new medications are substantial, amounting to several thousands of dollars over the course of treatment. » More
|
|
Pharmacists are being pressured into taking a "Do not fill" attitude, often toward legitimate pain treatments. The question arises, however, how the pharmacist is to know when a prescription is real or not? No pharmacist wants to be tricked into allowing controlled substances to head to the streets for sale. » More
|
|
Social media - whether blog posts, Facebook announcements, or Twitter messages - have become great tools for communicating and engaging with colleagues and patients. Social media enable pharmacists to join interest groups and interact with every member of each group. » More
|
|
For many experts, the $30+ billion over-the-counter dietary supplement market is a minefield studded with health hazards. Drug Topics board member Frederick S. Mayer, RPh, MPH, president of Pharmacists Planning Services, Inc., says that herbal products, vitamins, minerals, and specialty items are a mystery of marketing claims, and their risks and benefits are poorly understood by health professionals and consumers. » More
|
|
You really want in on a revolution you can win? You seriously want to play Che Guevara? Just pay attention. This is not a treacherous proposition. You have all the trump cards in this game. You just gotta play them. » More
|
|
|
Like
Tweet
